Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurphy, Kevin R.en
dc.contributor.authorEivindson, Arneen
dc.contributor.authorPauksens, Karlisen
dc.contributor.authorStein, William J.en
dc.contributor.authorTellier, Guyen
dc.contributor.authorWatts, Richard Walteren
dc.contributor.authorLeophonte, Paulen
dc.contributor.authorSharp, Stephen J.en
dc.contributor.authorLoeschel, Elkeen
dc.identifier.citationClinical Drug Investigation, 2000; 20(5):337-349en
dc.description.statementofresponsibilityKevin R. Murphy, Arne Eivindson, Karlis Pauksens, William J. Stein, Guy Tellier, Richard Watts, Paul Léophonte, Stephen J. Sharp, Elke Loeschelen
dc.publisherAdis Internationalen
dc.titleEfficacy and safety of inhaled Zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease. A double-blind, randomised, placebo-controlled, multicentre studyen
dc.typeJournal articleen
Appears in Collections:General Practice publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.